US Patent Issued to Alloy Therapeutics on Sept. 1 for "Identification of convergent antibody specificity sequence patterns" (Swiss Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,725,003, issued on Sept. 1, was assigned to Alloy Therapeutics Inc. (Waltham, Mass.).

"Identification of convergent antibody specificity sequence patterns" was invented by Simon Friedensohn (Riehen, Switzerland) and Sai Reddy (Basel, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present methods use a variational autoencoder (VAE) and deep generative modelling to learn meaningful representations from the immune repertoires. The system can map input sequences into a lower-dimensional latent space, which reveals a large amount of convergent sequence patterns. The system can identify patterns present in convergent clusters that are highly p...